Risk Factors Associated with Long COVID Syndrome: A Retrospective Study.
Background
Recently, people have recognized the post-acute phase symptoms of the COVID-19. We investigated the long-term symptoms associated with COVID-19, (Long COVID Syndrome), and the risk factors associated with it.


Methods
This was a retrospective observational study. All the consecutive adult patients referred to the healthcare facilities anywhere in Fars province from 19 February 2020 until 20 November 2020 were included. All the patients had a confirmed COVID-19 diagnosis. In a phone call to the patients, at least three months after their discharge from the hospital, we obtained their current information. The IBM SPSS Statistics (version 25.0) was used. Pearson Chi square, Fisher's exact test, t test, and binary logistic regression analysis model were employed. A P value of less than 0.05 was considered to be significant.


Results
In total, 4,681 patients were studied, 2915 of whom (62.3%) reported symptoms. The most common symptoms of long COVID syndrome were fatigue, exercise intolerance, walking intolerance, muscle pain, and shortness of breath. Women were more likely to experience long-term COVID syndrome than men (Odds Ratio: 1,268; 95% Confidence Interval: 1,122-1,432; P=0.0001), which was significant. Presentation with respiratory problems at the onset of illness was also significantly associated with long COVID syndrome (Odds Ratio: 1.425; 95% Confidence Interval: 1.177-1.724; P=0.0001). A shorter length of hospital stay was inversely associated with long COVID syndrome (Odds Ratio: 0.953; 95% Confidence Interval: 0.941-0.965; P=0.0001).


Conclusion
Long COVID syndrome is a frequent and disabling condition and has significant associations with sex (female), respiratory symptoms at the onset, and the severity of the illness.
['Akbar Asadi-Pooya|Ali|A|', 'Akbari|Ali|A|', 'Emami|Amir|A|', 'Lotfi|Mehrzad|M|', 'Rostamihosseinkhani|Mahtab|M|', 'Nemati|Hamid|H|', 'Barzegar|Zohreh|Z|', 'Kabiri|Maryam|M|', 'Zeraatpisheh|Zahra|Z|', 'Farjoud-Kouhanjani|Mohsen|M|', 'Jafari|Anahita|A|', 'Sasannia|Fateme|F|', 'Ashrafi|Shayan|S|', 'Nazeri|Masoume|M|', 'Nasiri|Sara|S|', 'Shahisavandi|Mina|M|']
COVID-19 Medicine SARS-CoV-2 Viruses